{"entity":{"id":"nct06914674","kind":"trial","name":"Tamoxifen for Advanced Solid Pseudopapillary Tumor of the Pancreas","aka":["SPTP"],"tldr":"A phase 2 trial in pancreatic cancer, run by Fudan University, now recruiting.","summary":"Tamoxifen for Advanced Solid Pseudopapillary Tumor of the Pancreas is a phase 2, interventional study registered as NCT06914674 by Fudan University, with a registry enrolment figure of 30 participants, started 2025-03-20 and due to reach its primary completion in 2027-02-28. Interventions recorded: Tamoxifen 20 mg. Conditions listed: Pancreatic Neoplasms. Primary outcome: Progression-free survival (PFSn). Pancreatic eligibility wording from the registry: \", pancreatitis)\". Sites: China. No results are recorded here; the registry entry is the source.","status":"recruiting","asOf":"2026-09-24","links":[{"label":"ClinicalTrials.gov NCT06914674","url":"https://clinicaltrials.gov/study/NCT06914674"}],"tags":["ctgov-ingest","pancreatic-deep-dive"],"related":[],"cancers":["metastatic-pdac"],"sections":[],"technologies":[],"targets":[],"drugs":[],"companies":[],"institutions":[],"pathways":[],"terms":[],"trials":[],"people":[],"bottlenecks":[],"keyPapers":[],"journals":[],"dependsOn":[],"notes":[],"nct":"NCT06914674","phase":"2","setting":"Tamoxifen for Advanced Solid Pseudopapillary Tumor of the Pancreas","sponsor":"Fudan University","enrolled":30,"enrolledBasis":"registry","outcomes":[]},"route":"/trials/nct06914674/","neighbours":{"cancer":[{"id":"metastatic-pdac","kind":"cancer","name":"Metastatic pancreatic ductal adenocarcinoma","route":"/cancers/metastatic-pdac/"}],"term":[{"id":"pancreatic-trials-open-today","kind":"term","name":"Pancreatic cancer trials open today (registry snapshot and UK sites)","route":"/terms/pancreatic-trials-open-today/"}]}}